MO
FY2026 Q1 · Calendar Q2 2026
Altria Group, Inc.
Altria delivered a stronger-than-expected Q1 FY2026, with adjusted diluted EPS of $1.32 (up 7.3% YoY) beating consensus by 5.6% and revenue of $4.76B exceeding estimates by 3.9%. The beat was driven by Marlboro's premium share gains (59.5%) and expanding smoke-free penetration via on! PLUS, which reached nationwide availability at ~100,000 stores. Despite the strong start, management reaffirmed rather than raised full-year EPS guidance of $5.56-$5.72, signaling a more conservative H2 outlook and drawing analyst scrutiny. The stock surged 6.5% on the report before drifting -4.2% in subsequent sessions, suggesting the market initially rewarded the beat but reconsidered the unchanged guidance and ongoing macro headwinds. Compared to Q4 2025, where EPS grew 4.4% and the focus was on initial FDA authorizations and the duty drawback program launch, Q1 2026 showed accelerating EPS growth…
EPS surprise+5.6%
Market move+6.5%
